Guardant Health Seeks Dismissal of Natera’s Sanctions Appeal in False Advertising Dispute

In an ongoing legal battle, Guardant Health has formally requested that a California federal judge dismiss the plea from Natera’s law firm, Quinn Emanuel Urquhart & Sullivan LLP, to mitigate sanctions prohibiting the use of clinical trial evidence in a false advertising case initiated by Guardant. The plea for leniency follows claims by the court that it had been “duped” by reportedly false and misleading assertions made by Natera’s expert and legal counsel. This development forms part of the complex litigation involving the two biotechnology companies, focusing on allegations of false advertising rooted in the presentation and interpretation of clinical trial data.